New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
04:55 EDTMRGE, MRGE, KND, KND, IMMU, IMMU, COO, COO, CVS, CVS, ARNA, ARNA, GMED, GMED, ISIS, ISIS, Q, Q, STML, STML, BDSI, BDSI, DEPO, DEPOWells Fargo to hold a conference
2014 Healthcare Conference to be held in Boston on June 17-18.
News For MRGE;BDSI;STML;Q;ISIS;GMED;ARNA;CVS;COO;IMMU;KND;DEPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 16, 2015
06:10 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Stocks with implied volatility below IV index mean; BlackBerry (BBRY) 63, Arena Pharmaceuticals (ARNA) 86 according to iVolatility.
January 15, 2015
18:28 EDTDEPOOn The Fly: After Hours Movers
Subscribe for More Information
16:08 EDTDEPOJ&J unit sells U.S. Nucynta license rights to Depomed for $1.05B
Subscribe for More Information
16:08 EDTDEPODepomed to acquire U.S. rights to NUCYNTA franchise for $1.05B from Jansen
Subscribe for More Information
16:05 EDTDEPODepomed to acquire U.S. rights to NUCYNTA franchise for $1.05B from Jansen
16:01 EDTDEPODepomed trading halted, pending news
07:13 EDTSTMLJPMorgan to hold a conference
Subscribe for More Information
06:04 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
05:26 EDTISISIsis receives orphan status for myotonic dystrophy drug treatment
Subscribe for More Information
January 14, 2015
10:21 EDTARNAOptions with decreasing implied volatility
Subscribe for More Information
07:37 EDTQ, KNDJPMorgan to hold a conference
Subscribe for More Information
07:05 EDTISISIsis Pharmaceuticals earns $7M from Biogen for advancing muscular atrophy study
Subscribe for More Information
06:03 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 13, 2015
11:14 EDTCVSCVS Health repeats FY15 adjusted EPS view $5.05-$5.19, consensus $5.13
CVS Health repeats forecast for FY15 revenue growth of 7%-8.25%, consensus $148.9B. CVS Health repeats forecast for FY15 free cash flow $5.9B-$6.2B. Previously issued FY15 guidance repeated in slides for JPMorgan Healthcare Conference presentation.
11:11 EDTCVSCVS Health says gaining share in growing Rx market
Subscribe for More Information
07:42 EDTCVSJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
06:02 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
January 12, 2015
10:24 EDTARNAOptions with increasing implied volatility
Options with increasing implied volatility: TLM GREK ARNA AVP
08:02 EDTARNAArena Pharmaceuticals initiates Phase 2 clinical trial evaluating ralinepag
Arena Pharmaceuticals announced the initiation of patient dosing in a Phase 2 clinical trial of ralinepag, an oral, non-prostanoid prostacyclin receptor agonist intended for the treatment of pulmonary arterial hypertension. This 22-week, randomized, double-blind and placebo-controlled Phase 2 trial will evaluate the hemodynamic and exercise capacity effects, safety and tolerability of ralinepag in up to 60 patients with PAH. During the first nine weeks of the trial, patients will be titrated to their individual tolerance level, and then sustained at this level for the remainder of the trial.
06:14 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use